Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
心脑欣片 (Xinnaoxin Pian) is a traditional Chinese medicine (TCM) developed and manufactured by Beijing Yushengtang Pharmaceutical. It is an oral tablet formulation composed of a complex blend of herbal and animal-derived ingredients, including *Rhodiola rosea*, *Lycium barbarum*, *Hippophae rhamnoides*, *Panax quinquefolius*, and *Salvia miltiorrhiza*. The medication is primarily indicated for the treatment of cardiovascular and cerebrovascular diseases associated with "Qi and Yin deficiency" and "blood stasis." It is used to alleviate symptoms such as chest tightness, palpitations, shortness of breath, headache, dizziness, and insomnia. Additionally, Xinnaoxin Pian is widely utilized for the prevention and treatment of altitude sickness due to its pharmacological properties that enhance hypoxia tolerance and improve microcirculation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on xinnaoxin pian.